CNS Pharmaceuticals, Inc. (CNSP) analyst actions
Rating and price-target actions on CNSP in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CNSP overview →
2 measured CNSP analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation | Press release | -5.88% | -4.12% | |
| CNS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Reiterates Company is on Track to Achieve Milestones for Berubicin Potentially Pivotal Study Before Year End | Press release | +0.00% | +10.35% |
Keep exploring
More CNSP: earnings → · SEC filings → · CNSP overview →